One platform for all researcher needs
AI-powered academic writing assistant
Your #1 AI companion for literature search
AI tool for graphics, illustrations, and artwork
Unlock unlimited use of all AI tools with the Editage All Access membership.
Explore Editage All Access
Open Accesshttps://doi.org/10.1182/blood-2020-136834
Copy DOI Journal: Blood |  Publication Date: Nov 5, 2020 |
 Citations: 44 |
Affiliation: Harvard University, Dana-Farber Cancer Institute, University of Miami, Sylvester Comprehensive Cancer Center, University of Rochester Medical Center, Ronald Reagan UCLA Medical Center, University of California, Los Angeles, Los Angeles Medical Center, Hôpital Lyon Sud, Columbia University Irving Medical Center, The Ohio State University, The University of Texas MD Anderson Cancer Center, Vanderbilt University Medical Center, UPMC Hillman Cancer Center, Inserm, Centre Hospitalier Universitaire de Lille, University of Lille, University of South Florida, Moffitt Cancer Center, Fred Hutch Cancer Center, Fox Chase Cancer CenterPrimary Analysis of Zuma-5: A Phase 2 Study of Axicabtagene Ciloleucel (Axi-Cel) in Patients with Relapsed/Refractory (R/R) Indolent Non-Hodgkin Lymphoma (iNHL)
Sign-in/Register to access full text options 
Free) Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
